-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Downgrades Artiva Biotherapeutics to Hold

Benzinga·10/27/2026 16:55:54
Listen to the news
Needham analyst Gil Blum downgrades Artiva Biotherapeutics (NASDAQ:ARTV) from Buy to Hold.